1 introduction to critical appraisal yulia lin, md, frcpc transfusion medicine & hematology...

57
1 Introduction to Introduction to Critical Appraisal Critical Appraisal Yulia Lin, MD, FRCPC Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre Sunnybrook Health Sciences Centre University of Toronto University of Toronto TMR Journal Club, September 6, 2011 TMR Journal Club, September 6, 2011

Upload: madisyn-tann

Post on 01-Apr-2015

216 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

11

Introduction to Introduction to Critical AppraisalCritical Appraisal

Yulia Lin, MD, FRCPCYulia Lin, MD, FRCPC

Transfusion Medicine & Hematology Transfusion Medicine & Hematology

Sunnybrook Health Sciences CentreSunnybrook Health Sciences Centre

University of TorontoUniversity of Toronto

TMR Journal Club, September 6, 2011TMR Journal Club, September 6, 2011

Page 2: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

22

Why is Critical Appraisal Why is Critical Appraisal important?important?

Page 3: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

33

Vast amount of literatureVast amount of literature

Page 4: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

44

New Studies inTransfusion

Page 5: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

55

New Studies inTransfusion

Past Studies in Transfusion

Page 6: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

66

New Studies inTransfusion

Past Studies in TransfusionStudies in other Sub-specialties

Page 7: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

77

Why critical appraisal is important?Why critical appraisal is important?

Impossible to keep up with all of the Impossible to keep up with all of the literatureliterature

Enables us to distinguish stronger Enables us to distinguish stronger evidence from weaker evidenceevidence from weaker evidence

Allows us to appropriately incorporate the Allows us to appropriately incorporate the evidence into our practice so as to evidence into our practice so as to improve patient careimprove patient care

Page 8: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

88

Transfusion Medicine Residency ObjectivesTransfusion Medicine Residency Objectives ScholarScholar 2 - Evaluate medical information and its sources 2 - Evaluate medical information and its sources

critically, and apply this appropriately to practice critically, and apply this appropriately to practice decisionsdecisions• Describe the principles of critical appraisalDescribe the principles of critical appraisal• Critically appraise retrieved evidence in order to address Critically appraise retrieved evidence in order to address

a clinical questiona clinical question• Integrate critical appraisal conclusions into clinical careIntegrate critical appraisal conclusions into clinical care• Critically review published literature and apply Critically review published literature and apply

appropriate utilization principles/practices /guidelinesappropriate utilization principles/practices /guidelines

Page 9: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

99

Purpose of TMR Journal ClubPurpose of TMR Journal Club

1.1. To present a recent article in the To present a recent article in the transfusion literaturetransfusion literature

2.2. To learn how to critically appraise the To learn how to critically appraise the medical literature medical literature

Page 10: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

1010

Steps to a successful JCSteps to a successful JC

1.1. Choosing the articleChoosing the article

2.2. Presenting the articlePresenting the article

3.3. Critically appraising the articleCritically appraising the article

Page 11: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

1111

Choosing an article…Choosing an article…

Where to find an article?Where to find an article?• Recent table of contents Recent table of contents

NEJM, Lancet, JAMANEJM, Lancet, JAMA Transfusion, Vox Sanguinis, Blood, etc.Transfusion, Vox Sanguinis, Blood, etc.

• Transfusion Medicine Reviews – Journal ClubTransfusion Medicine Reviews – Journal Club• Transfusion Medicine CommunityTransfusion Medicine Community• List of interesting articlesList of interesting articles

Page 12: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

1212

Choosing the article…Choosing the article…

Which article?Which article?• RelevantRelevant• Interesting to youInteresting to you

What type of article?What type of article?• Any articleAny article• But some are easier than others…But some are easier than others…

Page 13: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

1313

Type of articlesType of articles

Randomized controlled trials – TherapyRandomized controlled trials – Therapy Observational studies – HarmObservational studies – Harm Systematic ReviewsSystematic Reviews GuidelinesGuidelines

DiagnosisDiagnosis PrognosisPrognosis

Page 14: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

1414

First, a review…First, a review…

Page 15: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

1515

Randomized Controlled TrialRandomized Controlled Trial

Population Randomization

Intervention A

Intervention B

Outcomesmeasured

Page 16: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

1616

Randomized Controlled TrialRandomized Controlled Trial

Population Randomization

Intervention A

Intervention B

Outcomesmeasured

Which article?

Page 17: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

1717

Randomized Controlled TrialRandomized Controlled Trial

Randomization

Fill in the blanks above:Population? Intervention? Outcome?

Page 18: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

1818

Randomized Controlled TrialRandomized Controlled Trial

Population Randomization

Intervention A

Intervention B

Outcomesmeasured

Which article?

Page 19: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

1919

Randomized Controlled TrialRandomized Controlled Trial

Randomization

Fill in the blanks above:Population? Intervention? Outcome?

Page 20: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

2020

Observational Case-ControlObservational Case-Control

Population

Cases(+Disease)

Control(No disease)

Exposure to Risk Factor

Exposed

Yes

No

Yes

No

Page 21: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

2121

Observational Case-ControlObservational Case-Control

Population

Cases(+Disease)

Control(No disease)

Exposure to Risk Factor

Exposed

Yes

No

Yes

No

Retrospective

Page 22: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

2222

Observational Case-ControlObservational Case-Control

Population

Cases(+Disease)

Control(No disease)

Exposure to Risk Factor

Exposed

Yes

No

Yes

No

Which article?

Page 23: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

2323

Observational Case-ControlObservational Case-Control

Cases?

Controls?

Risk factor?

Exposed

Yes

No

Yes

No

Fill in the blanks:Population? Who are the cases and controls?

What are the risk factors?

Page 24: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

2424

Observational CohortObservational Cohort

Cohort

Cohort without Disease

Exposure to Risk Factor

Population

Exposed

Not exposed

Disease

Yes

No

Yes

No

Page 25: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

2525

Cohort StudiesCohort StudiesPast Present Future

Follow-upCohort assembled

RetrospectiveCohort Study

Page 26: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

2626

Cohort StudiesCohort StudiesPast Present Future

Follow-upCohort assembled

RetrospectiveCohort Study

Which article?

Page 27: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

2727

Cohort StudiesCohort StudiesPast Present Future

Fill in the blanks:Who is the cohort? What is the risk factor? What is the outcome?

Page 28: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

2828

Cohort StudiesCohort StudiesPast Present Future

Follow-upCohort assembled

RetrospectiveCohort Study

Follow-upCohort assembled

ProspectiveCohort Study

Page 29: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

2929

Cohort StudiesCohort StudiesPast Present Future

Follow-upCohort assembled

RetrospectiveCohort Study

Follow-upCohort assembled

ProspectiveCohort Study

Which article?

Page 30: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

3030

Cohort StudiesCohort StudiesPast Present Future

Follow-upCohort assembled

RetrospectiveCohort Study

Fill in the blanks above:Who is the cohort? What is the risk factor? What is the outcome?

Page 31: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

3131

Systematic ReviewSystematic Review

OverviewOverview• Summary of the medical literature that Summary of the medical literature that

attempts to address a focused clinical questionattempts to address a focused clinical question Systematic reviewSystematic review

• Using methods designed to reduce the Using methods designed to reduce the likelihood of biaslikelihood of bias

Meta-analysisMeta-analysis• Review that uses quantitative methods to Review that uses quantitative methods to

summarize the resultssummarize the results

Page 32: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

3232

Systematic ReviewSystematic Review

Systematic reviewSystematic review• Using methods designed to reduce the Using methods designed to reduce the

likelihood of biaslikelihood of bias Meta-analysisMeta-analysis

• Review that uses quantitative methods to Review that uses quantitative methods to summarize the resultssummarize the results

Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced platelets.

Vamvakas EC. Transfusion May 2011;51:1058-71

Page 33: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

3333

GuidelinesGuidelines

““Systematically developed statements to Systematically developed statements to assist practitioner and patient decisions assist practitioner and patient decisions about appropriate health care for specific about appropriate health care for specific clinical circumstances”clinical circumstances”• Attempt to address all issues and values relevant Attempt to address all issues and values relevant

to a clinical decisionto a clinical decision• Attempt to distill a large body of medical Attempt to distill a large body of medical

expertise into a convenient, readily usable formatexpertise into a convenient, readily usable format• Make explicit recommendations with definite Make explicit recommendations with definite

intent to influence what clinicians dointent to influence what clinicians do

Field MJ. Clinical practice guidelines. 1990Hayward et al. JAMA 1995;274:570-4

Cook et al. Ann Int Med 1997;127:210-6

Page 34: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

3434

GuidelinesGuidelines

““Systematically developed statements to Systematically developed statements to assist practitioner and patient decisions assist practitioner and patient decisions about appropriate health care for specific about appropriate health care for specific clinical circumstances”clinical circumstances”

Guidelines on oral anticoagulation with warfarin, 4th edition. BCSH 2010.

http://www.bcshguidelines.com/documents/warfarin_4th_ed.pdf

Page 35: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

3535

How to do a critical appraisal?How to do a critical appraisal?

Page 36: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

3636

Critical appraisal methodsCritical appraisal methods

Most are based on Users’ Guides to the Most are based on Users’ Guides to the Medical Literature Medical Literature • Available in a textbook form (2Available in a textbook form (2ndnd ed) ed) • Brief version Brief version http://

www.ebem.org/usersguide.html For guidelines, different instrumentsFor guidelines, different instruments

• AGREE instrument: AGREE instrument: http://www.agreetrust.org/resource-centre/agree-ii/

Page 37: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

3737

Page 38: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

3838

Steps to Critical AppraisalSteps to Critical Appraisal

1.1. Are the results valid?Are the results valid?• Have the results been influenced in a Have the results been influenced in a

systematic fashion so as to lead to a false systematic fashion so as to lead to a false conclusion?conclusion?

2.2. What are the results?What are the results?

3.3. How can I apply the results to patient How can I apply the results to patient care? care?

Page 39: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

3939

Page 40: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

4040

Page 41: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

4141

RCTRCT

Population Randomization

Intervention A

Intervention B

Outcomesmeasured

Page 42: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

4242

RCT - Are the results valid?RCT - Are the results valid?

Population Randomization

Intervention A

Intervention B

Outcomesmeasured

Was the assignment of patients to treatment randomized?Were all patients who entered the trial accounted for and attributed at its conclusion?Were patients, clinicians and study personnel kept "blind" to treatment received?Were the groups similar at the start of the trial?Aside from the experimental intervention were the groups treated equally?

Page 43: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

4343

RCT - Are the results valid?RCT - Are the results valid?

Randomization

Adherence totransfusion strategies

Was the assignment of patients to treatment randomized?Were all patients who entered the trial accounted for and attributed at its conclusion?Were patients, clinicians and study personnel kept "blind" to treatment received?Were the groups similar at the start of the trial?Aside from the experimental intervention were the groups treated equally?

Elective cardiac SurgeryN=50

RestrictiveHb <70 CPBHb <75 postop

LiberalHb <95 CPBHb <100 postop

Page 44: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

4444

RCT - What were the results?RCT - What were the results?

Population Randomization

Intervention A

Intervention B

Outcomesmeasured

How large was the treatment effect?How precise was the estimate of the treatment effect?

Page 45: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

4545

RCT - What were the results?RCT - What were the results?

Population Randomization

Intervention A

Intervention B

Outcomesmeasured

How large was the treatment effect?How precise was the estimate of the treatment effect?

Page 46: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

4646

RCT - How can I apply the RCT - How can I apply the results to patient care?results to patient care?

Population Randomization

Intervention A

Intervention B

Outcomesmeasured

Can the results be applied to my patients?

Page 47: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

4747

RCT - How can I apply the RCT - How can I apply the results to patient care?results to patient care?

Population Randomization

Intervention A

Intervention B

Outcomesmeasured

Can the results be applied to my patients?Were all clinically important outcomes considered?Are the likely treatment benefits worth the potential harm and costs?

Page 48: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

4848

Observational CohortObservational Cohort

Cohort

Cohort without Disease

Exposure to Risk Factor

Population

Exposed

Not exposed

Disease

Yes

No

Yes

No

Page 49: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

4949

Cohort StudiesCohort StudiesPast Present Future

Incidence of TRALIPts receivinghigh plasmavolume donations from LAPS II

LAPS II: a retrospective cohort study of transfusion-relatedacute lung injury in recipients of high-plasma-volume human

Leukocyte antigen antibody-positive or –negative components.Kleinman et al. Transfusion. Published online Mar 29, 2011.

Exposure to HLA ab posvs neg donations

Page 50: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

5050

Cohort - Are the results valid?Cohort - Are the results valid?

Pts receivinghigh plasma

volume donations

from LAPS II

Cohort without Disease

Exposure to Risk Factor

All hospitalpatients

HLA ab pos

HLA ab neg

Disease

TRALI

No

TRALI

No

Except for the exposure under study, were the compared groups similar to each other?Were the outcomes and exposures measured in the same ways in both groups?Was the follow-up of patients sufficiently long and complete?Is the temporal relationship correct?Is there a dose-response gradient?

Page 51: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

5151

Cohort - Are the results valid?Cohort - Are the results valid?

Pts receivinghigh plasma

volume donations

from LAPS II

Cohort without Disease

Exposure to Risk Factor

All hospitalpatients

HLA ab pos

HLA ab neg

Disease

TRALI

No

TRALI

No

Except for the exposure under study, were the compared groups similar to each other?Were the outcomes and exposures measured in the same ways in both groups?Was the follow-up of patients sufficiently long and complete?Is the temporal relationship correct?Is there a dose-response gradient?

Page 52: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

5252

Cohort - What are the results?Cohort - What are the results?

Cohort

Cohort without Disease

Exposure to Risk Factor

Population

Exposed

Not exposed

Disease

Yes

No

Yes

No

How strong is the association between exposure and outcome? Consider magnitude and dose response?How precise is the estimate of the risk?

Page 53: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

5353

Cohort - What are the results?Cohort - What are the results?

Cohort

Cohort without Disease

Exposure to Risk Factor

Population

Exposed

Not exposed

Disease

Yes

No

Yes

No

How strong is the association between exposure and outcome? Consider magnitude and dose response?How precise is the estimate of the risk?

Page 54: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

5454

Cohort - How can I apply the results?Cohort - How can I apply the results?

Cohort

Cohort without Disease

Exposure to Risk Factor

Population

Exposed

Not exposed

Disease

Yes

No

Yes

No

Are the results applicable to my patients?

Page 55: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

5555

Cohort - How can I apply the results?Cohort - How can I apply the results?

Cohort

Cohort without Disease

Exposure to Risk Factor

Population

Exposed

Not exposed

Disease

Yes

No

Yes

No

Are the results applicable to my patients?What is the magnitude of the risk?Should I attempt to stop the exposure?

Page 56: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

5656

Putting it all together…Putting it all together…

Page 57: 1 Introduction to Critical Appraisal Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology Sunnybrook Health Sciences Centre University of Toronto TMR

5757

Tips for TMR Journal ClubTips for TMR Journal Club

Choose the article carefully Choose the article carefully Include brief background for contextInclude brief background for context Present the article briefly (10 slides)Present the article briefly (10 slides) The main objective is the critical appraisalThe main objective is the critical appraisal

• Internal validity: Internal validity: Focus on 1-2 key pointsFocus on 1-2 key points Explain one concept (bias, statistical test)Explain one concept (bias, statistical test)

• External validity: Take a standExternal validity: Take a stand Allow 20-30 minutes for discussionAllow 20-30 minutes for discussion